Improve the dupilumab therapy evaluation with dermoscopy and high‐frequency ultrasound in moderate‐to‐severe atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory disease. Monoclonal antibody dupilumab was approved to treat moderate‐to‐severe AD in recent years. An objective assessment of treatment response by skin imaging modality is adjuvant for clinical evaluations. This study aimed to explore th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaorui, Niu, Zihan, Zhang, Dingding, Liu, Jie, Zhu, Qingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838759/
https://www.ncbi.nlm.nih.gov/pubmed/36704877
http://dx.doi.org/10.1111/srt.13260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838759/
https://www.ncbi.nlm.nih.gov/pubmed/36704877
http://dx.doi.org/10.1111/srt.13260

Ejemplares similares